RISK FACTORS AND CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA OCCURING IN HCV CIRRHOTIC PATIENTS AFTER SUSTAINED VIROLOGICAL RESPONSE

被引:0
|
作者
Payance, A. [1 ]
Goutte, N. [1 ]
Clair, E. [1 ]
Paradis, V. [2 ]
Bouattour, M. [1 ,3 ]
Vullierme, M. -P. [4 ]
Castelnau, C. [1 ]
Boyer, N. [1 ]
Farges, O. [5 ]
Asselah, T. [1 ]
Durand, F. [1 ]
Bedossa, P.
Marcellin, P. [1 ]
Castera, L. [1 ]
机构
[1] BEAUJON, Hepatol, Clichy, France
[2] BEAUJON, Anatomopathol, Clichy, France
[3] BEAUJON, Oncol, Clichy, France
[4] BEAUJON, Radiol, Clichy, France
[5] BEAUJON, Hepatobiliary & Pancreat Surg, Clichy, France
关键词
D O I
10.1016/S0168-8278(16)00436-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-041
引用
收藏
页码:S320 / S320
页数:1
相关论文
共 50 条
  • [1] Effect of sustained virological response to interferon plus ribavirin on the incidence of hepatocellular carcinoma in HCV cirrhotic patients.
    Cheinquer, H
    Cheinquer, N
    Coelho-Borges, S
    Juruena, CS
    Peres, DS
    Wolff, F
    HEPATOLOGY, 2004, 40 (04) : 323A - 323A
  • [2] PREDICTIVE FACTORS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HCV-RELATED ADVANCED FIBROSIS AND SUSTAINED VIROLOGICAL RESPONSE
    Cardoso, Ana Carolina F.
    Carvalho-Filho, Roberto J.
    Stern, Christiane
    Figueiredo-Mendes, Claudio G.
    Giuily, Nathalie
    Ripault, Marie-Pierre
    Asselah, Tarik
    Martinot-Peignoux, Michelle
    Bedossa, Pierre
    Marcellin, Patrick
    HEPATOLOGY, 2009, 50 (04) : 1103A - 1103A
  • [3] Sustained virological response is associated with a lower risk of complications and hepatocellular carcinoma in patients with HCV related cirrhosis
    Cardoso, A. C.
    Moucari, R.
    Giuily, N.
    Figuciredo-Mendes, C.
    Boyer, N.
    Ripault, M. P.
    Castelnau, C.
    Asselah, T.
    Martinot-Peignoux, M.
    Maylin, S.
    Bedossa, P.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S290 - S290
  • [4] LOWER RISK OF HEPATOCELLULAR CARCINOMA AND IMPROVED SURVIVAL IN PATIENTS WITH HCV RELATED CIRRHOSIS WITH SUSTAINED VIROLOGICAL RESPONSE
    Cardoso, Ana Carolina F.
    Moucari, Romi
    Giuily, Nathalie
    Figueiredo-Mendes, Clau-dio G.
    Boyer, Nathalie
    Ripault, Marie-Pierre
    Castelnau, Corinne
    Asselah, Tarik
    Mortinot-Peignoux, Michele
    Maylin, Sarah
    Stern, Christiane
    Bedossa, Pierre
    Marcellin, Patrick
    HEPATOLOGY, 2008, 48 (04) : 428A - 428A
  • [5] Nonzero Risk of Hepatocellular Carcinoma Even after Sustained Virological Response
    Lee, Hyun Woong
    GUT AND LIVER, 2016, 10 (05) : 661 - 662
  • [6] Factors Associated with a Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR)
    Lau, Jason
    Krassenburg, Lisette A. P.
    Zanjir, Wayel M. R.
    Georgie, Firass
    Cerocchi, Orlando
    Stotland, Emily
    Morales, Heidy
    Janssen, Harry L. A.
    Hansen, Bettina E.
    Feld, Jordan J.
    HEPATOLOGY, 2018, 68 : 902A - 902A
  • [7] Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response
    Pinzone, M. R.
    Zanghi, A. M.
    Rapisarda, L.
    D'Agata, V
    Benanti, F.
    Sparta, D.
    Nunnari, G.
    Cacopardo, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 : 11 - 15
  • [8] Risk Factors of Hepatocellular Carcinoma After Treatment and Obtaining Sustained Viral Response in HCV Genotype 3 Patients
    Nguyen, Kelvin T.
    Kawamoto, Jenna K.
    Sheinbaum, Alan
    GASTROENTEROLOGY, 2016, 150 (04) : S1064 - S1064
  • [9] Factors implicated in the risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis due to HCV. Implications of Sustained Virological Response (SVR)
    Castano, A.
    Gomez, A.
    Torner, M.
    Fraile, M.
    Alvarez-Navascues, C.
    Cadahia-Rodrigo, V.
    Dieguez, M. L. G.
    Varela, M.
    Rodriguez, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S431 - S432
  • [10] Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection
    Nirei, Kazushige
    Kanda, Tatsuo
    Nakamura, Hitomi
    Matsuoka, Shunichi
    Takayama, Tadatoshi
    Sugitani, Masahiko
    Moriyama, Mitsuhiko
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2018, 15 (05): : 466 - 474